Search results
7 Cheap Value Stocks to Buy Now: May 2024
InvestorPlace· 6 days agoThe major stock market indexes are near record highs. The good news, however, is that investors can still put money to work in today’s market without...
AstraZeneca (AZN) to Build $1.5B Cancer Drug Plant in Singapore
Zacks· 24 hours agoThis new plant will be AstraZeneca's (AZN) first manufacturing facility for producing novel antibody drug conjugates from start to finish. It is scheduled to open in 2029.
There Is Value to Be Found in Drug Stocks
TheStreet.com· 9 hours agoHealthcare offers some rare bargains in the current market. Unfortunately, the current market is more picked over than some of the garage sales my mother...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 6 days agoLike other early-stage biotech companies, Gyre has reported years of annual losses, though came in...
These Healthcare Stocks Could Make A Great Addition To Any Passive Income Portfolio
Benzinga via Yahoo Finance· 3 days agoHealthcare stocks could make an attractive addition to your portfolio in May 2024, thanks to their...
Riding Recent Success in the High-Beta Biotech Sector
TheStreet.com· 2 days agoThis small-cap concern has multiple 'shots on goal' within its pipeline and a major strategic...
Walmart Posts Upbeat Earnings, Joins Canada Goose, Lightspeed Commerce And Other Big Stocks Moving...
Benzinga· 5 days agoThe 13F filing revealed Berkshire Hathaway had purchased 25.92 million Chubb shares valued at over...
Daily Brief: The Nvidia Rush
Quartz· 7 days agoFrance got a $16 billion cash infusion from the likes of Microsoft, Amazon, and Pfizer. Gold is still the first choice for many investors looking to...
Vepdegestrant shows promise in breast cancer trial By Investing.com
Investing.com· 5 days agoArvinas, Inc. (NASDAQ: ARVN) and Pfizer Inc. (NYSE: NYSE:PFE) today announced continued positive...
JD Supra: The SEC Secures Major Trial Victory in Its First ‘Shadow Trading’ Insider Trading...
JD Supra· 4 days agoThe jury found that the executive had breached a duty of “trust, confidence or confidentiality” by purchasing stock in a competitor company based on nonpublic information ...
